Preparing For the Return of FDA Surveillance Inspections: A Guide for Pharmaceutical Manufacturers

In July, acting FDA commissioner Janet Woodcock announced that the FDA would be resuming non-mission-critical facility inspections, effective immediately. In this article, we’re going to discuss what that means for pharmaceutical companies, and how they can prepare for a successful audit.   

Read More